Sweden-based Mölnlycke Health Care has extended its agreement with Apria Healthcare, allowing patients across the US to benefit from advanced wound care technology.
The new technology limits spreading of the wound exudate and can be removed with minimal skin stripping and pain.
Apria is currently taking fulfilment and service support for the Avance Max Negative Pressure Wound Therapy (NPWT) system to acute facilities across the US.
Across the US, acute care settings will benefit from the combination of the Avance NPWT with Safetac technology and Apria’s class service and support infrastructure for logistics and billing management.
The combination will benefit patients by minimising skin reactions and pain during dressing removal, improving overall patient comfort.
Apria has a dedicated support team in place, with a 24-hour hotline supported by professionals at Mölnlycke Health Care.
Available for acute care settings, the Avance Max NPWT system is designed to maximise NPWT care in the hospital, offering a clinically proven, cost-effective solution for the treatment of wounds.
Mölnlycke Health Care CEO Richard Twomey said: "As the leading supplier of advanced wound care solutions along the continuum of care, we are delighted to bring the benefits of negative pressure wound therapy to more patients in the US.
"Our products are clinically proven to reduce pain at dressing change and our solutions are designed to make it easier for patients to enjoy their own healing journey."
Avance Max will complement the Avance Flex NPWT system in home care, where Apria is the exclusive US distributor for Mölnlycke Health Care, in providing efficient hospital-to-home transitions and home care NPWT management.
Apria Healthcare CEO Dan Starck said: "Together, Apria and Mölnlycke Health Care are delivering advanced wound care therapy across the nation in a bigger way than ever before, with an overall better patient experience.
"Patient transitions from hospital to home, and the therapy hand-off are easier and more consistent with the Avance system in use from end to end.
"Transition planning upon admission with product continuity is now possible, benefitting patients and healthcare professionals alike."